Ann Færden

Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies

Altered fecal microbiota composition in patients with major depressive disorder

Which comes first: atypical antipsychotic treatment or cardiometabolic risk?

Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010

The Effect of Physical Activity Interventions on Children’s Cognition and Metacognition: A Systematic Review and Meta-Analysis

Association between Genetic Variation in the Oxytocin Receptor Gene and Emotional Withdrawal, but not between Oxytocin Pathway Genes and Diagnosis in Psychotic Disorders

Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters

Potential mechanisms of atypical antipsychotic-induced metabolic derangement: Clues for understanding obesity and novel drug design

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

Metabolic Syndrome Associated with Schizophrenia and Atypical Antipsychotics

Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia

What is the impact of mental health-related stigma on help-seeking? A systematic review of quantitative and qualitative studies

Can Long-Term Outcomes Be Improved by Shortening the Duration of Untreated Illness in Psychiatric Disorders? A Conceptual Framework

Age at onset and the outcomes of schizophrenia: A systematic review and meta‐analysis

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

Health states for schizophrenia and bipolar disorder within the Global Burden of Disease 2010 Study

Suicidality before and in the early phases of first episode psychosis

Is there an optimal factor structure of the Positive and Negative Syndrome Scale in patients with first‐episode psychosis?

Neurocognitive Dysfunction in Bipolar and Schizophrenia Spectrum Disorders Depends on History of Psychosis Rather Than Diagnostic Group

Apathy and Functioning in First-Episode Psychosis

Dyslipidemia Independent of Body Mass in Antipsychotic-Treated Patients Under Real-Life Conditions

Definitions of the Term ‘Recovered’ in Schizophrenia and Other Disorders